
1. Rev Gastroenterol Peru. 2017 Oct-Dec;37(4):394-398.

[Porphyria cutanea tarda as extrahepatic manifestation of chronic hepatitis C: a 
case report].

[Article in Spanish]

Espinoza-Ríos J(1), Valenzuela Granados V(1), Ojeda Cisneros M(2), Gálvez Canseco
A(3), Ramos Aguilar C(3), Raymundo Villalva B(3), Aguilar Sánchez V(2), Pinto
Valdivia J(1), Huerta-Mercado Tenorio J(4), Bussalleu Rivera A(5).

Author information: 
(1)Servicio de Gastroenterología, Hospital Cayetano Heredia. Lima, Perú; Facultad
de Medicina, Universidad Peruana Cayetano Heredia. Lima, Perú.
(2)Servicio de Gastroenterología, Hospital Cayetano Heredia. Lima, Perú.
(3)Servicio de Dermatología, Hospital Cayetano Heredia. Lima, Perú.
(4)Facultad de Medicina, Universidad Peruana Cayetano Heredia. Lima, Perú;
Servicio de Gastroenterología, Clínica Angloamericana. Lima, Perú.
(5)Facultad de Medicina, Universidad Peruana Cayetano Heredia. Lima, Perú.

The present case is a 56 year old male who present hyperpigmented and
hypopigmented scars in both hands, associated with the presence of milia cysts.
It was studied the metabolism of porphyrins and skin biopsy of the lesions which 
were compatible with porphyria cutanea tarda. In the initial laboratory, elevated
transaminases values were found and subsequently identified chronic infection of 
hepatitis C virus. In order to treat viral infection and resolve the dermal
commitment; considered extrahepatic manifestation of hepatitis C virus, treatment
was started with pegylated interferon and ribavirin, with favorably development
and rapid viral response, with undetectable viral load until now (24 weeks of
treatment), decreased level of serum transaminases and improvement of skin
lesions.


PMID: 29459814  [Indexed for MEDLINE]

